人气
计算机科学
医学实验室
检测点注意事项
考试(生物学)
医疗保健
数据科学
医学物理学
系统工程
风险分析(工程)
医学
工程类
病理
心理学
生物
古生物学
社会心理学
经济
经济增长
作者
B. G. Andryukov,I. N. Lyapun,М. П. Бынина,E. V. Matosova
出处
期刊:Klinicheskaia laboratornaia diagnostika
[EKOlab]
日期:2020-09-17
卷期号:65 (10): 611-618
被引量:5
标识
DOI:10.18821/0869-2084-2020-65-10-611-618
摘要
Immunochromatographic test systems known to foreign laboratory diagnostic experts as lateral flow immunoassay (LFIA) are simplified tape formats of modern biosensors. For 60 years, they have been widely used for the rapid detection of target molecules (ligands) in biosubstrates and the diagnosis of many diseases and conditions. The growing popularity of these test systems for providing medical care or diagnostics in developing countries, medical facilities, in emergency situations, as well as for individual home use by patients while monitoring their health are the main factors contributing to the continuous development and improvement of these methods, the emergence of a new generation of formats. The attractiveness and popularity of these fast, easy-to-use, inexpensive and portable diagnostic tools is associated primarily with their high analytical sensitivity and specificity, as well as the ease of interpretation of the results. These qualities have passed the test of time, and today LFIA test systems are fully consistent with the modern world concept of «point-of-care testing», finding wide application not only in medicine, but also in ecology, veterinary medicine, and agriculture. This review will highlight the modern principles of designing the most widely used formats of immunochromatographic test systems for clinical laboratory diagnostics, summarize the main advantages and disadvantages of the method, as well as current achievements and prospects of LFIA technology. Modern innovations aimed at improving the analytical characteristics of LFIA technology are interesting, promising and can bring additional benefits to immunochromatographic platforms that have gained popularity and attractiveness for six decades.
科研通智能强力驱动
Strongly Powered by AbleSci AI